1. Home
  2. CTKB vs BVS Comparison

CTKB vs BVS Comparison

Compare CTKB & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • BVS
  • Stock Information
  • Founded
  • CTKB 1990
  • BVS 2011
  • Country
  • CTKB United States
  • BVS United States
  • Employees
  • CTKB N/A
  • BVS N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CTKB Health Care
  • BVS Health Care
  • Exchange
  • CTKB Nasdaq
  • BVS Nasdaq
  • Market Cap
  • CTKB 718.8M
  • BVS 656.9M
  • IPO Year
  • CTKB 2021
  • BVS 2021
  • Fundamental
  • Price
  • CTKB $3.65
  • BVS $7.82
  • Analyst Decision
  • CTKB Buy
  • BVS Strong Buy
  • Analyst Count
  • CTKB 2
  • BVS 4
  • Target Price
  • CTKB $7.00
  • BVS $15.00
  • AVG Volume (30 Days)
  • CTKB 908.8K
  • BVS 339.2K
  • Earning Date
  • CTKB 05-07-2025
  • BVS 05-06-2025
  • Dividend Yield
  • CTKB N/A
  • BVS N/A
  • EPS Growth
  • CTKB N/A
  • BVS N/A
  • EPS
  • CTKB N/A
  • BVS N/A
  • Revenue
  • CTKB $200,453,000.00
  • BVS $573,280,000.00
  • Revenue This Year
  • CTKB $4.87
  • BVS N/A
  • Revenue Next Year
  • CTKB $8.74
  • BVS $6.09
  • P/E Ratio
  • CTKB N/A
  • BVS N/A
  • Revenue Growth
  • CTKB 3.85
  • BVS 11.89
  • 52 Week Low
  • CTKB $3.27
  • BVS $3.90
  • 52 Week High
  • CTKB $7.63
  • BVS $14.38
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 38.95
  • BVS 37.22
  • Support Level
  • CTKB $3.27
  • BVS $7.56
  • Resistance Level
  • CTKB $3.80
  • BVS $8.66
  • Average True Range (ATR)
  • CTKB 0.25
  • BVS 0.61
  • MACD
  • CTKB 0.03
  • BVS -0.05
  • Stochastic Oscillator
  • CTKB 45.78
  • BVS 28.40

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: